Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Abbvie Inc

Recent news which mentions Abbvie Inc

Ad spending on women's sports more than doubled last year
Tags Abbvie Inc Basketball Business
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Health care industry Microsoft Corp AstraZeneca PLC
From CNBC.com News
Cramer's Lighting Round: AbbVie is a buy
Tags S&P 500 Investing Market Outlook
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Companies Social issues Teva Pharmaceutical Industries Ltd
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags DR Horton Inc Amgen Inc KB Home
From CNBC.com News
Cramer's Lightning Round: Sweetgreen is 'terrific'
Tags Market Outlook Stock markets Abbvie Inc
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Brown & Brown Inc Walmart Inc Universal Health Services Inc
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Breaking news Amgen Inc Merck & Co Inc
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Johnson & Johnson Healthy Returns Breaking News: Politics
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Tags Teva Pharmaceutical Industries Ltd Abbvie Inc Health & Science
From CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Tags Health care industry Abbott Laboratories Breaking news
From CNBC.com News
After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return
Tags Breaking News: Technology Space industry Technology
From CNBC.com News
Cramer's Lightning Round: AbbVie is 'a very good company'
Tags Markets Investment strategy Mad Money
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags Health care industry Alvotech SA Daiichi Sankyo Co Ltd
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
Tags Johnson & Johnson Business News Biotech and Pharmaceuticals
From CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
Tags Investment strategy Markets Mad Money
From CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
Tags Seagen Inc Pfizer Inc Health care industry
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Economy Walmart Inc JPMORGAN DRN
From CNBC.com News
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
Tags Abbvie Inc Companies Biotechnology
From CNBC.com News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Tags Pfizer Inc Seagen Inc Health care industry
From CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
Tags Investment strategy Datadog Inc CNBC Investing Club: Newsletter
From CNBC.com News
Cramer's Lightning Round: Energy Transfer is a buy
Tags Mad Money Portillos Inc Markets
From CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
Tags Merck & Co Inc Breaking news Amgen Inc
From CNBC.com News
Federal judge declines to block Medicare price negotiations
Tags Medicare health plans Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
Tags Politics Companies Breaking news
From CNBC.com News
CVS pushes further into generic drugs with Sandoz partnership for new discount Humira
Tags Amgen Inc CVS Health Corp Health care industry
From CNBC.com News
These 10 medications are likely targets for Medicare price negotiations this fall
Tags US: News Policy Bristol/Myers Squibb Co
From CNBC.com News
Hepatitis C cure is not reaching overwhelming majority of patients due to financial barriers
Tags Biotech and Pharmaceuticals Breaking News: Business Business News
From CNBC.com News
Cramer's Lightning Round: Get rid of ADT
Tags Datadog Inc Investment strategy Markets
From CNBC.com News
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
Tags Merck & Co Inc Amgen Inc Social issues
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.